Renovia Announces FDA 510(k) Clearance of Next-Generation leva® Pelvic Digital Therapeutic

by Renovia | Nov 26, 2019 | Press Releases

Boston, MA – November 25, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic device and app technologies for women with pelvic floor disorders, today announced U.S. Food and Drug...

Renovia Study Results Published in Neurology and Urodynamics Show Positive Results for leva® Pelvic Digital Therapeutic in Treating Female Urinary Incontinence

by Renovia | Aug 7, 2019 | Press Releases

Study Demonstrates Improvements in Objective Pelvic Floor Muscle Measures, Patient-Reported Urinary Incontinence Severity and Condition-Specific Quality of Life, with Results Evident after 1 Week of Use Boston, MA – August 7, 2019 – Renovia Inc. (“Renovia”), a company...

Renovia Inc. Nominated for MedTech Company of the Year at the New England Venture Capital Association’s 2019 NEVYs Awards

by Renovia | Mar 28, 2019 | Press Releases

Boston, MA – March 28, 2019 – Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced that it has received a nomination for MedTech Company...

Renovia Names Jim O’Connor as General Counsel & Senior Vice President, Strategic Development

by Renovia | Mar 14, 2019 | Press Releases

Boston, MA – March 14, 2019– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced Jim O’Connor has been promoted to General Counsel...

Renovia Appoints John A. Fallon, M.D. to its Board of Directors

by Renovia | Jan 9, 2019 | Press Releases

Boston, MA – January 9, 2019– Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced John A. Fallon, M.D. has joined its Board of...

Renovia Launches “REDUCE” – a Multi-Center Randomized Controlled Trial to Study Next-Generation leva® Pelvic Digital Therapeutic System for Urinary Incontinence

by Renovia | Nov 12, 2018 | Press Releases

Six-Center Study Will Compare Renovia’s Pelvic Digital Therapeutic System to Standard of Care Pelvic Floor Muscle Exercises in Home-based Treatment of Stress-dominant Urinary Incontinence Boston, MA – November 12, 2018 – Renovia Inc. (“Renovia”), a company dedicated...